Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Psychological Adjustment Following Extreme Therapeutic Responses to Anti-Calcitonin Gene-Related Peptide (CGRP) Treatment in Patients With Chronic Migraine: A Mixed Quantitative and Qualitative Study

NCT07877493 is registered in ClinicalTrials.gov with Central Hospital, Nancy, France as lead sponsor.

NCT NCT07877493
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07877493 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Psychological Adjustment Following Extreme Therapeutic Responses to Anti-Calcitonin Gene-Related Peptide (CGRP) Treatment in Patients With Chronic Migraine: A Mixed Quantitative and Qualitative Study
Lead sponsor
Central Hospital, Nancy, France
Phase
Observational
Overall status
Not yet recruiting
Start date
October 31, 2026
Completion date
October 31, 2026
Enrollment
30 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic migraine headache, psychologic adaptation